Medadvisor Limited

MDR

MedAdvisor Ltd. engages in the provision of mobile and web software platform for prescription medication use. The company is headquartered in Melbourne, Victoria. The company went IPO on 2011-05-26. The Company’s segments include Australia, the United States, the United Kingdom and Asia Operations. Its product suite is built upon a medication data platform that supports a patient app, a pharmacy-based module PlusOne, and digital health programs, all of which are connected to dispensing networks. The company provides one-tap access to the details of the pharmacy, including phone number, email, opening hours and show-on-map/navigation. The Company’s subsidiaries include MedAdvisor International Pty. Ltd., Health Enterprises 2 Pty. Ltd., Health Enterprises 2 Pty. Ltd., MedAdvisor Welam USA Inc. and Adheris, LLC.

Mindax Limited

MDX

Mindax Ltd. engages in the exploration and development of mineral properties. The company is headquartered in Perth, Western Australia. The company went IPO on 2004-12-08. The Company’s portfolio of projects includes iron ore and gold. Its projects include the Mt Forrest Iron Project, Mt Lucky Gold project and Meekatharra North Project. The Mt Forrest iron project is in the Yilgarn province. The company comprises seven mining leases and is located 600 kilometers (km) from the Port of Geraldton and 165 km from the southbound railway at Menzies and around 648 km from the port at Esperance. The project is a world-scale iron ore resource. The Meekatharra North Project comprises one granted exploration license, E51/1705. The Meekatharra North Project is a gold-mining center in the Murchison Goldfields of Western Australia. The project is located 40 km north of the township of Meekatharra, at the northern end of the Meekatharra Greenstone Belt, in the Murchison Province, Western Australia. Mt Lucky lies within the Mt Margaret Mineral Field of the north-eastern Goldfields of Western Australia.

Mercury NZ Limited

MCY

Mercury NZ Ltd. engages in the generation and distribution of electricity from hydro, geothermal, and gas. The firm generates electricity from renewable resources, such as hydro, geothermal and wind. Its products and services consist of generation/wholesale and retail. Generation/wholesale market segment encompasses activity associated with electricity generation, electricity trading, generation development activities. The company is engaged in sale of electricity to both commercial and industrial customers and the retail segment. Retail segment encompasses activity associated with sale of energy, and related services, to customers in New Zealand. The retail operations serve commercial and residential (small medium sized businesses) customers. The company offers pre-pay electricity product, GLOBUG. The company manages several subsidiary enterprises, such as its EV Subscription Service. The firm is also engaged in the business of gas, telecommunications business, and retail electricity supply business.

Medlab Clinical Limited

MDC

Medlab Clinical Ltd. engages in the development of therapeutic pathways for diagnosed chronic diseases. The company is headquartered in Alexandria, New South Wales. The company went IPO on 2015-07-14. The firm is investigating a range of prescription and non-prescription solutions for unmet patient needs across a variety of therapeutic areas, including pain management, mental health, gut health, diabetes, and allergies. The Company’s drug candidates include NanaBis, NanoCBD and NanoCelle. Medlab’s pipeline comprises a range of small and large molecules from repurposing generic medicines to enhancing the delivery of immunotherapies. The firm's lead drug candidate, NanaBis, is under development for cancer bone pain as an alternative to opioid use and NanoCBD for mental stress . The firm also has a drug delivery platform called NanoCelle, which is wholly owned by Medlab and developed in Medlab’s owned Office of the Gene Technology Regulator (OGTR) registered laboratory.